Zai Lab (ZLAB) Receives a Buy from Cantor Fitzgerald
at www.tipranks.com (Mon, 26-Oct 10:39 AM)
Zai Lab spotlights 81.8% response rate for chemo-free zoci + atezolizumab regimen in first-line ES-SCLC
Market Chameleon (Fri, 23-Oct 7:05 AM)
Zai Lab announces $250M private placement
at seekingalpha.com (Fri, 23-Oct 2:26 AM)
